Top compounds associated with response to RARS


Feature Type Standardized
Nominal ANOVA
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.11 0.001
mRNA YM-155 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.1 0.001
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA austocystin d CTRPv2 pan-cancer AAC -0.12 0.001
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.097 0.001
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV